Form 4: RxSight CEO Ronald Kurtz Exercises Stock Options and Sells Shares
SEC Form 4 Filing
RxSight's CEO, Ronald Kurtz, exercised stock options and sold shares of common stock on July 11, 2024, according to a recent SEC filing.
Summary
- On July 11, 2024, Ronald M. Kurtz, the President and CEO of RxSight, Inc., exercised stock options to acquire 13,500 shares of common stock at a price of $15.0818 per share.
- Simultaneously, Kurtz disposed of 13,500 shares of common stock.
- Following these transactions, Kurtz directly owns 26,836 derivative securities and indirectly owns 764,610 shares through Cricklewood LP.
- The exercised options were granted under the company's 2015 Equity Incentive Plan and vest monthly, starting from April 23, 2020.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to insider transactions, which doesn't inherently convey positive or negative sentiment. It's a factual disclosure.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. Investors often monitor these filings to gauge management's sentiment about the company's prospects.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it involves the CEO's personal investment decisions.
Key Dates
| Date | Description |
|---|---|
| April 23, 2020 | Vesting Commencement Date for the stock options. |
| June 13, 2024 | Date of execution for the Power of Attorney. |
| July 11, 2024 | Date of the stock option exercise and share disposal. |
| July 12, 2024 | Date of signature for the SEC filing. |
| April 22, 2030 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.